The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia

Top, Tuncay; Sekerci, ÇAĞRI; Isbilen-Basok, Banu; TANIDIR, YILÖREN; TİNAY, İLKER; İŞMAN, FERRUH; Akbal, Cem; ŞİMŞEK, FERRUH; TARCAN, TUFAN

doi:10.1002/nau.23207

The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia

Atıf İçin Kopyala

Top T., Sekerci Ç. A., Isbilen-Basok B., TANIDIR Y., TİNAY İ., İŞMAN F. K., ...Daha Fazla

NEUROUROLOGY AND URODYNAMICS, cilt.36, sa.7, ss.1896-1902, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 7
Basım Tarihi: 2017
Doi Numarası: 10.1002/nau.23207
Dergi Adı: NEUROUROLOGY AND URODYNAMICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1896-1902
Anahtar Kelimeler: nerve growth factor, transforming growth factor beta 1, tissue inhibitor of matrix metalloproteinase 2, botulinum neurotoxin type A, myelodysplasia, NERVE GROWTH-FACTOR, BLADDER, OBSTRUCTION, INJECTIONS, FIBROSIS, TOXIN, SECONDARY
Marmara Üniversitesi Adresli: Evet

Özet

AimsThe aim of this study was to determine the value of urine nerve growth factor (NGF), transforming growth factor beta 1 (TGF-Beta-1), tissue inhibitor of matrix metalloproteinase 2 (TIMP-2) levels to predict the urodynamic profile before and after botulinum neurotoxin type A (BoNT-A) treatment in children with myelodysplasia.